Drugs / TALC ANHYDROUS
TALC ANHYDROUS
also known as
TALC · E-553(III) · Huashifen · INS NO.553(III) · INS-553(III) · Pulvis talci · Purified talc · Sclerosol · +4 more
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT06742099 | Dec 2024 → Jun 2025 overdue | pleural neoplasm | Assiut University | Not yet recruiting | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT03827070 | Mar 2019 → Feb 2023 | non-small cell lung carcinoma | Center Trials & Treatment Europe | Unknown | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT06883188 | Nov 2026 → Oct 2029 expected | pneumothorax | Chinese University of Hong Kong | Not yet recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00002872 | Jan 1997 → Feb 2003 | metastatic malignant neoplasm | Eastern Cooperative Oncology Group | Completed | No outcome recorded |
| Comparator or background therapy6 trials | ||||||
| Phase 1/2 | NCT04130451 Comparator | Oct → Dec 2019 | pneumothorax | Dow University of Health Sciences | Unknown | No outcome recorded |
| Phase 2 | NCT02054078 Comparator | Jan 2012 → Mar 2014 | pleural neoplasm | Tang-Du Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT02674243 Comparator | Nov 2015 → Dec 2019 | pleural neoplasm | Chiang Mai University | Completed | No outcome recorded |
| Phase 3 | NCT00002622 Comparator | Dec 1994 → Mar 2005 | metastatic malignant neoplasm | Alliance for Clinical Trials in Oncology | Completed | No outcome recorded |
| Phase 4 | NCT04792970 Comparator | Mar 2021 → Oct 2022 | pleural neoplasm | Duke University | Terminated | No outcome recorded Stop: Enrollment |
| — | NCT03973957 Comparator | May 2019 → Jan 2021 | pleural neoplasm | The Cooper Health System | Unknown | No outcome recorded |
Evidence & citations 15 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TALC ANHYDROUS | ChEMBL registry synonym — accepted as the source's own label CHEMBL3990276 ↗ |
| Known as | E-553(III) | ChEMBL registry synonym — accepted as the source's own label CHEMBL3990276 ↗ |
| Known as | Huashifen | ChEMBL registry synonym — accepted as the source's own label CHEMBL3990276 ↗ |
| Known as | INS NO.553(III) | ChEMBL registry synonym — accepted as the source's own label CHEMBL3990276 ↗ |
| Known as | INS-553(III) | ChEMBL registry synonym — accepted as the source's own label CHEMBL3990276 ↗ |
| Known as | Pulvis talci | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02054078 ↗ |
| Known as | Purified talc | ChEMBL registry synonym — accepted as the source's own label CHEMBL3990276 ↗ |
| Known as | Sclerosol | ChEMBL registry synonym — accepted as the source's own label CHEMBL3990276 ↗ |
| Known as | Steritalc | ChEMBL registry synonym — accepted as the source's own label CHEMBL3990276 ↗ |
| Known as | TALC | “Some drugs such as bleomycin or doxycycline, or other compounds like talc, may help to control fluid in the chest caused by cancer.” NCT00002872 ↗6“the injection of Talc in pleural space to induce inflammation reaction and produce pleurodesis” NCT06742099 ↗ |
| Known as | talc powder | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06883188 ↗ |
| Known as | Talcum | ChEMBL registry synonym — accepted as the source's own label CHEMBL3990276 ↗ |
| Known as | Talcum powder | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03827070 ↗ |
| Modality | Small molecule | — CHEMBL3990276 ↗ |
| Route | Other | “via indwelling pleural catheter” NCT03973957 ↗ |